BLOODO
LIVE

Serial Number

97691365

Owner

FUNDACIJA

Attorney

Nicholas D. Wells

Filing Date

Nov 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BLOODO Trademark

Serial Number: 97691365 • Registration: 7797913

BLOODO is a trademark filed by FUNDACIJA on November 24, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

FUNDACIJA

Pamenkalnio g. 36-2
Vilnius 01114 , LT

Entity Type: 16

Trademark Details

Filing Date

November 24, 2022

Registration Date

May 20, 2025

Published for Opposition

April 1, 2025

Goods & Services

Reagents for medical use, namely, reagents for blood grouping; Test strips for measuring blood glucose levels; Chemical preparations for medical purposes, namely, for testing blood to detect metabolic disorders and diagnose endocrine disorders

Medical testing of blood; Medical services relating to the removal, treatment and processing of human blood; Medical services relating to the removal, treatment and processing of umbilical cord blood; Therapy services, namely, nutritional therapy and cognitive-behavioral therapy (CBT); Endocrinology therapy, namely, providing thyroid hormone (TTH) management medical services for hypothyroidism, as well as estrogen, testosterone, and other hormone level monitoring and adjustment medical services; Pharmacotherapy, namely, medication management and optimization being medical services involving the incorporation of laboratory-based medical testing of HbA1c for diabetes management, NAD testing for determining optimal supplement dosages, fatty acid profiling for omega supplement recommendations, and vitamin D level assessments, along with additional biomarkers being metabolic, nutritional, hormonal, inflammatory, genetic, and detoxification markers measurable from human samples; Biofeedback therapy, namely, providing medical information based on the analysis of various biomarkers being vitamin levels, hormone levels, and other measurable factors being metabolic, inflammatory, genetic, and detoxification markers; Gene therapy, namely, genetic testing to identify predispositions for genetic conditions or assess future disease risks for medical purposes; Herbal medicine therapy, namely, health assessment services regarding the effects of herbal remedies on biological markers being vitamin D levels, fatty acids, HbA1c, and based on the analysis of various biomarkers being vitamin levels, hormone levels, and other measurable factors being metabolic, inflammatory, genetic, and detoxification markers to evaluate their efficacy; Medical and healthcare services; Health screening services in the field of metabolic disorders and endocrine disorders; Medical services; Professional consulting services in the field of healthcare

Blood filters; Filters for blood and blood components for medical purposes; Apparatus for taking blood; Blood testing apparatus; Blood collection needles; Blood testing apparatus, namely, blood collection tubes for medical use; Blood lancets

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 20, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 20, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 13, 2025 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 17, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 25, 2024 GNFN
FINAL REFUSAL E-MAILED
Nov 25, 2024 GNFR
FINAL REFUSAL WRITTEN
Nov 25, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 1, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2024 CRFA
ASSIGNED TO LIE
Apr 4, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 6, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 20, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2022 NWOS
NEW APPLICATION ENTERED
Nov 28, 2022 NWAP